Analysis of the Modulation of Serum Hepcidin Level in Response to Iron Oral Intake: Potential Interest for the Differential Diagnosis Between Ferroportin Disease and Dysmetabolic Hepatosiderosis.
Clinical trial NCT01949467 · COMPLETED
Trial details
- NCT number
- NCT01949467
- Sponsor
- Rennes University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-10
- Primary completion
- 2017-12-19
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.